John Libbey Eurotext




Treatment of an infantile acne with oral isotretinoin
European Journal of Dermatology. Volume 14, Number 1, 71-2, January-February 2004, Clinical report
Free Article
Author(s) : F. SARAZIN, A. DOMPMARTIN, S. NIVOT, D. LETESSIER, D. LEROY
Summary : We report the case of a little girl who presented with a nodulocystic acne which had its onset at the age of 20 months. She had no clinical or biological features of endocrinopathy. The lesions did not respond to conventional antibiotics so she was started on oral isotretinoin. A seven‐month treatment period was necessary to achieve remission. The onset of infantile acne is usually around 6 to 16 months and there is a male predominance. The onset is later in females. Oral erythromycin is the first line treatment when topical therapies are inefficacious. Some cystic lesions do not respond to oral antibiotics. In these cases, oral isotretinoin may be effective and the treatment is similar to that of an adult. Clinical and biological tolerance is good with no growth retardation. Lesions may relapse after the withdrawal of isotretinoin but they are less important and easily controlled with topical treatments. Isotretinoin can be used for nodulocystic acne to reduce the risk of scarring.
Keywords : infantile acne, isotretinoin

Treatment of an infantile acne with oral isotretinoin